A
Absence of structural heart disease 235
ACE See Angiotensin-converting enzyme
ACE inhibitors 393
ACEI See Angiotensin-converting enzyme inhibitors
Acetazolamide 119
Acetylsalicylic acid 155
Acquired immunodeficiency syndrome-induced heart failure 543
Actinomyces 507
Activated partial thromboplastin time 241
Active antiretroviral therapy, highly 542
Acute
agitation/anxiety 410
aortic regurgitation 59
atrial fibrillation 27
cardiac complications 500
cardiomyopathy trial 517
care 426
congestive heart failure, management of 19
in heart failure 152
treatment of 154
medications indicated in 156
prognostic value in 268
exacerbation of chronic obstructive pulmonary disease 44
fulminant myocarditis 509
biomarkers in 110
in emergency department, treatment of 15
inotropes in different clinical settings of 135t
management using systolic blood pressure 17
prognostic value in 268
role of ultrasound in management of 54
study 121
treatment of 15
trial, biomarkers in 548
ischemic heart disease 199
maxillary sinusitis 84
mitral regurgitation 58
pericarditis 200
pulmonary
respiratory
failure 77
ST-elevation myocardial infarction 494
treatment of sustained ventricular tachycardia 235
valvular heart disease 57
Acutely destabilized heart failure 140
Adaptative-pressure-control 77
Adequate blood pressure 124
ADH analogues 147
Adherence to guideline-based medications 375
Administer sliding scale heparin infusion adjustment 171
Adrenergic system 535
Adrenocorticotropic hormone 144
Adrenomedullin 549
Adults with congenital heart disease 98
Advance care planning program 377
Advanced glycation end-products 341
AIDS-induced cardiac abnormalities and heart failure 541
Akinesia of mid-ventricle 497f
Aldactone evaluation study, randomized 218
Ambulatory capacity 103
AMC See Acute myocarditis
Amiloride 119
Amino N-terminal prohormone 37
Amino-terminal pro-B-type natriuretic peptide 71
Amiodarone 28
Amyloidosis 480
Amyotrophic lateral sclerosis 4
Anderson-Fabry disease 482
Anemia See Nutritional deficiencies
doses of 438
in heart failure 214
insertion polymorphism 534
inhibitors 19, 48, 85, 119, 181, 188, 208, 213, 215, 218, 223, 245, 258, 268, 270, 276, 278, 281, 285, 286, 296, 299, 317, 328, 334, 348, 375, 373, 384, 399, 415, 421, 428–430, 543
receptor blockers 141, 188, 208, 214, 258, 259, 268, 270, 271, 276, 281, 285, 296, 317, 328, 373, 375, 399, 415, 421, 429, 430, 438, 542
therapy 334
treatment algorithm 428
Antibiotics 147
Anticoagulation therapy in heart failure with sinus rhythm 242
Antidepressants 147
Antidiabetic agents 343
Antidiuretic hormone 118
Antihypertensives 147
Antineoplastic agents 147
Antipsychotic drugs 147
Antithrombotic therapy in heart failure patients in sinus rhythm, role of 246
Antiviral immunomodulation with interferon 517
Apical hypokinesia 497f
Apixaban for reduction in stroke 242
Apoptotic myocardial cell death in heart failure 290f
Arbovirus 507
Arenavirus 507
Arrhythmic right-ventricular cardiomyopathy/dysplasia 232
Artificial hearts 393
ARVC See Arrhythmogenic right-ventricular cardiomyopathy
Ascaris 507
Asymptomatic heart failure 417
Atrial
enlargement 274
and heart failure 230
classifications 22
flutter 274
in acute setting 23
in patients with heart failure and preserved, management of 21
Atrioventricular dissociation 233f
Autoantibodies 513
Autosomal recessive 525f
Average volume-assured pressure support 77
AVRC See Arrhythmogenic right-ventricular cardiomyopathy
B
Balloon triggering and timing 469
Beats per minute 490
Benzafibrate infarction prevention 245
Beriberi 388
Beta blockers and proper dosing 216t
Beta-blocker treatment algorithm 429
Bilateral renal artery stenosis 214
Biopsy 477
Bisoprolol 216
BIV function, assessments of 99
Biva in dyspneic patients, use of 68
Biventricular pacing 264
B-lines 70
Blood
cultures, multiple positive 200
metabolic profile 171
urea
and serum electrolyte 429
volume estimation 165
BNP See brain natriuretic peptide
Bone marrow mononuclear cells 398
Borrelia species 507
Bradycardia 216
Breath, shortness of 543
Breathing 23
British National Health Service 365
Brockenbrough sign 487
Broken heart syndrome’ 494
Brucella species 507
Brugada criteria 234
Building blocks of successful ultrafiltration therapy program 168
Bumetanide 119
Burden of heart failure 109
Bystander coronary disease 496
C
CAD See Coronary artery disease
Calcified mitral valve 60
Carbohydrate antigen-125 302
Carbon monoxide 5
Carbonic anhydrase inhibitors 119
Cardiac
abnormalities associated with elevation of B-type natriuretic peptide 274t
arrhythmia 449
catheterization 495
chamber
enlargement 94
size 274
dysfunction 102
function
assessment of 104
heart failure with aldosterone antagonist trial, treatment of 329
implantable electronic devices 261
index 182
intensive care units 73
diagnosis of myocarditis 512
findings in myocarditis, dynamics of 513f
in takotsubo cardiomyopathy 499f
myosin activators 134
output 167
rehabilitation ward 426
resynchronization 398
recommendation for 265
use of 209
siderosis 482
case of 57
transplantation 50
in hospitalized patients, recommendations for 293
in management of patients with congestive heart failure 289
in outpatients with heart failure, recommendations for 294
release in patients with heart failure 289
use of 293
Cardiomems heart sensor 209
Cardiopulmonary exercise stress testing 188
Cardiorenal rescue study in acute decompensated heart failure 163
Cardiotoxic drugs, use of 47
CAST See cardiac arrhythmia suppression trial
Catecholaminergic polymorphic VT 232
Catheter ablation 229
CCB See Calcium channel blocker
Cell adhesion molecules 507
Cerebrovascular accident 246
CHF See Chronic heart failure
Chlamydia pneumonia 507
Chlamydophila psittaci 507
Chlorthalidone 119
Chlorthiazide 119
Chordal rupture 57
Chorea minor See also Sydenham's chorea
Chronic
dilated cardiomyopathy 506
disease, role of 376
cause of 151
definition of advanced 438
prognostic value in 267
therapy, outpatient tailored 353
ischemic heart disease 199
progressive external ophthalmoplegia 532
pulmonary disease 12
renal insufficiency 89
treatment of 400
valvular heart disease 57
ventricular tachycardia, treatment of 236
viral cardiomyopathy 517
CICUS See Cardiac intensive care units
Circulation 23
CK-MB See Creatine kinase-MB
Classes of inotropes and mechanism of action 131
Claustrophobia 90
Clopidogrel 155
Clostridium tetani 507
CMR See Cardiac magnetic resonance imaging
Cohort studies, epidemiological 243t
Comet tails 70
Community, prognostic value in 268
Comorbidities, management of other 105
Complaint of dyspnea 4
Congestive heart failure 22, 24, 29, 29t, 48, 97f, 110, 179, 190, 198, 216, 225, 233, 258, 358, 373f, 420, 431
evaluation of mechanical assistance for treatment of 444
Randomized evaluation of mechanical assistance for treatment of 451
Constrictive pericarditis 97f
Continuous flow left ventricular assist device 458
Converting enzyme inhibitors 45
COPD See Chronic obstructive pulmonary disease
Coronary
artery
bypass grafting combines with
cell transplantation 398
Corynebacterium diphtheria 507
Coxiella burnetii 507
Coxsackie-adenovirus receptor 507
Creatine kinase-MB 543
Critical pulmonary edema or hypercapnia 22
CRT, cardiac resynchronization therapy 264
CTN See Cardiac troponins
Current exacerbation of HF 215
CVD, prevention of 394
Cyanide 5
Cystatin C 301
Cytomegalovirus 507
Cytotoxic T lymphocytes 507
D
DCM See Dilated cardiomyopathy
DCMI See Dilated cardiomyopathy with inflammation
Deep vein thrombosis 243
Dengue virus 507
Determining optimal heart failure therapy 317
Device and surgical procedures 393
Diabetic ketoacidosis 4
Diagnosis of chronic heart failure 298
Diagnostic algorithm for dyspneic patients, proposal of 71
Diet compliance, medication and 191
Digitalis 228
with inflammation 508
Dipeptidyl peptidase-4 inhibitors 344
Disability-adjusted life years 370
Discontinuation of ultrafiltration therapy 175
Disease, patterns of 495
Disposition of emergency department 8
Distal convoluted tubule 118
Distension of inferior vena cava 200
optimization strategies evaluation 158
pharmacokinetics and dosing of 119t
therapy in hospital 121
treated heart failure 159
Dizziness 11
DNA See Deoxyribonucleic acid
Dofetilide 28
Driveline infection 457
Dynamic molecular targets in heart failure 535
E
Echinococcosis 507
Echocardiogram 226
Echocardiographic evaluation 487
Echovirus 507
Edema in lower extremities 410
Effect of mitral regurgitation 246
Effective regurgitant orifice 199
Electrical cardioversion 28
Electrocardiography 487
EMB See Endomyocardial biopsy
Embolus, source of 201
Emergency
department observation
chart for patient 83f
unit 80
department patient with suspected acute heart failure syndrome 16
Enalapril 215
Encephalomyocarditis 507
End-of-life issues 465
Endothelial dysfunction 342
End-stage heart failure 443
End-systole 497f
Entamoeba histolytica 507
Epinephrine 131
Eplerenone 119
Eplerenone post-acute myocardial infarction heart failure efficacy and survival study 218
Erythema marginatum of acute rheumatic fever 390f
Erythrocyte sedimentation rate 543
Erythropoiesis-stimulating agents 337
ESR See Erythrocyte sedimentation rate
Ethanol septal ablation 491
Evaluating hyponatremia 146
Evidence-based markers of acute heart failure risk 10t
Exacerbation 216
Exercise regimen 191
Expiratory positive airway pressure 76
External jugular vein 327f
F
Fatigue 410
Female sex category 24
Fibrosis 274
Filling pressures 274
Flavivirus 507
Flecainide 28
Food and drug administration 46
Forrester's classification 62
Framingham heart study 311
Francisella tularensis 507
Frank-Starling curve 404
Furosemide 119
G
Gastric inhibitory polypeptide 344
GCMC See Giant cell myocarditis
Genetic
and risk stratification 531
based risk stratification 529
diagnosis 531
of cardiomyopathy 524
diseases 522
heterogeneity 529
of sarcomeric hypertrophic cardiomyopathy 531
in heart failure caused by multifactorial diseases 534
test of cardiomyopathy 524
in dilated cardiomyopathy 528
in heart failure, applications of 536
Geriatric syndrome model of heart failure 323f
Giant cell myocarditis 515
Glycemic control, role of 342
Glyceraldehyde-3-phosphate dehydrogenase 341
Glycoprotein 156
Good death, principles of 463
Guideline-directed medical therapy 265
Guiding heart failure care with natriuretic peptides 273
H
Haemophilus influenzae 507
HCM See Hypertrophic cardiomyopathy
Heart
attack 504
block 216
disease
right 201
failure 4, 27, 40, 48, 54, 80, 87, 89, 101, 104, 143, 182, 183, 198, 203, 204, 210, 213, 215, 219, 223, 238, 249, 261, 275, 284, 286, 292, 311, 322, 324, 325, 336, 337, 340, 347, 351, 353, 377, 388, 396, 402, 415, 426, 427, 429, 430, 439, 447, 451, 461, 522, 526, 536, 546, 549
advanced 377
and acute coronary syndrome 151
and atrial fibrillation 239
causes of 388
classification of 81
clinic 429
disease management 410
in nursing homes 408
registery study of 396
in diabetes, pathophysiology of 341
in Europe 347
in hospital 107
in primary care 348
in southeast Asia 369
long-term antithrombotic study 246
management of 333
congestive 80
managing adults with 417
morbidity, reduction of 220
multinational study in 268
pathophysiology of 375
patient
daily review chart 430t
discharge planning 432
with symptomatic 420
prevention strategies 318
progressive 508
readmission 205f
relevant structural 256
risk
and mortality 534
of advanced 439t
typical of 256
stage
B 370
diagnosis of 542
management of patient with 255
Heartmate vented electric left ventricular assist system 377
Heartware ventricular assist device 377
Helminthic diseases 507
Hematocrit monitoring, technical aspects of 174
Hematologic function 449
Hemorrhagic shock 6
Hepatic function 449
Hepatojugular reflux 121
Heterophile-blocking tubes 290
HF See Heart failure
HFPEF, management of 329
High dependency unit 426
High flow nasal cannula 77
High-dose chemotherapy 296
HIV See Human immunodeficiency virus
HNCM See Hypertrophic nonobstructive cardiomyopathy
HOCM See Hypertrophic obstructive cardiomyopathy
Home-based palliative disease management 377
Hydralazine 180
Hydrochlorthiazide 119
Hydrogram 66
Hydrograph 66
Hyperglycemia, without 145
Hyperkinesia of apical and basal regions 497f
Hyperlipidemia 152
Hypertensive
acute heart failure syndrome pathway 17
and normotensive acute heart failure, therapies for 19
heart disease 371
Hypertrophic
nonobstructive cardiomyopathy 491
Hypertrophy 274
Hyperuricemia 125
Hypokalemia 6
in heart failure 143
treatment of 146
in HF, presence of 146
in stage d heart failure 148
treatment of 145
Hypotensive acute heart failure syndrome pathway 18
Hypothalamic-pituitary-adrenal axis 547
I
ICD See Implantable cardioverter defibrillator
Iceberg phenomenon 190
IHD See Idiopathic heart disease
Immunoadsorption 517
Immunohistological aspects of dilated cardiomyopathy with inflammation 511f
Immunomodulatory treatment 516
Immunosuppression 516
Impaired excitation contraction coupling 341
Implantable
Inappropriate antidiuretic hormone, syndrome of 146
Infectious agents 507t
Infective endocarditis 391f
Initiation of angiotensin-converting enzyme inhibitors 213
Inspiratory positive airway pressure 76
Interpretation of natriuretic peptide values in ambulatory heart failure 274
Intravenous
immunoglobulin treatment 517
nitroglycerin 127
non-potassium sparing loop diuretics 19
pyelogram 84
Iodinated contrast for computed tomography 90
Isosorbide dinitrate 180
L
Labile international normalized ratios 240
LBBB, left bundle branch block 264
candidacy evaluation 183
in China 399
infection 457
fraction, reduced 218
fractions 63, 92, 236, 242, 255, 257, 262–265, 268, 285, 294, 296, 313, 343, 374, 393, 399, 445, 454, 478, 485, 515
end diastolic
diameter 509
volume index 257
end-systolic volume 478
filing pressures 62
mass 370
masses and thrombus, evaluation of 97
Legionella pneumophila 507
Leishmaniasis 507
Leptospira 507
Levosimendan 133
Lightheadedness 410
Lipid-lowering therapy 156
Lisinopril 215
Liver function 240t
Long QT syndrome 232
Low left ventricular ejection fraction 244
Low-density lipoprotein 156
Low-dose dobutamine stress magnetic resonance 93
Lower natriuretic peptide concentrations 281
Lupus erythematosus 152
Lutz frankenstein 364
LVAD See Left ventricular assist device
LVEDP See Left ventricular end-diastolic pressure
LVEF See Left ventricular ejection fraction
LVNC See Left ventricular
LVOTO See Left ventricular outflow tract obstruction
M
Magnetic resonance angiography 399
Major histocompatibility complex 511
Malaria 507
Malignant arrhythmias 507
Management and conventional heart failure treatment 514
Matrilineal inheritance of cardiomyopathies 525f
Matrix metalloproteinase-9 140
Mean
arterial blood pressure 509
corpuscular hemoglobin 336
corpuscular volume 336
pulmonary
artery pressure 182
capillary wedge pressure 257
rehospitalization equivalents 162f
Metallic implants 88
Metalloproteinase-9 140
Metastatic renal cell carcinoma 90f
Meteor 145
Metformin 343
Metolazone 119
in patients with heart failure 218
Ministry of Health 425t
Minnesota living with heart failure questionnaire 376
Moderate-to-severe respiratory distress 76f
Monitor during diuresis 123
MRNA See Messenger ribonucleic acid
Mr-Proadm See Midregional proadrenomedullin
MR-ProANP See Mid-region proatrial natriuretic peptide
MRSA, methicillin-resistant staphylococcus aureus 457
Multicenter
automatic defibrillator implantation trial ii 262
INSYNC ICD randomized clinical evaluation 264
Multisystem organ failure 444
Myocardial
processes 274
Myopericarditis 514
N
for emergency department 43
for guiding heart failure management 276
function 42
in acute coronary syndrome 47
in general inpatient setting 114
in inpatient setting 109
pathophysiology 41
role for 12
Nebivolol 216
Neisseri 507
Nephrotic syndrome 143
New biomarkers in emergency department 40
New cardiovascular disease biomarkers in hospital medicine 139
Newer inotropes 133
Next generation sequencing 528
Nicotinamide adenine dinucleotide phosphate 341
Nitroprusside 128
NIV with acute pulmonary edema 78
Nomenclature of indication of mechanical circulatory support 453
Non-cardiogenic dyspnea 61
Noncommunicable diseases, prevalence of 426
Noncompaction cardiomyopathy 98
Noncompliance to medications 426
Nonpharmacological measures 394
Non-sarcomeric hypertrophic cardiomyopathy 531
Nonsteroidal anti-inflammatory drugs See also Calcium channel blocker
Nonsustained ventricular tachycardia 262
Nonsustained VT 232
Noradrenaline 431
Norepinephrine 131
Normal sinus rhythm 454
Normotensive acute heart failure syndrome pathway 18
NSAIDs See Nonsteroidal anti-inflammatory drugs
NSTEMI See Non-ST-segment elevation myocardial infarction
NT-ProBNP See N-terminal pro-B-type natriuretic peptide
Nuclear imaging 481
Nutrition 456
P
Painkillers 147
Paragonimus westermani 507
Parasternal long axis 57
PASP See Pulmonary artery systolic pressures
Patent foramen ovale 455
Pathogenesis of virus-induced acute cardiomyopathy 508f
Patient self care 206
Patient-centered heart failure care 466f
Peak expiratory flow rate 12
Pedigrees in autosomal dominant 525f
Percutaneous
mechanical circulatory support in cardiogenic shock 468
transluminal septal myocardial ablation 491
Pharmacologic cardioversion 28
Phosphodiesterase III inhibitors 133
Physical inactivity 370
Pleural effusion 6
Pneumothorax 6
Polyarteritis nodosum 152
Polymerase chain reaction 506
Polymorphic VT 233
Poor perfusion, symptoms of 191
Post HOC analyses of clinical trials 244
Postdischarge management 105
Post-myocardial infarction 218
Potassium-sparing diuretics 119
Prasugrel 155
Pressure assisted-controlled ventilation 76
Pretransplant evalution 182
Primary care physician 354
Proadrenomedullin 548
Procainamide 28
Prohormone levels in heart failure 546
Propafenone 28
Proportional assist ventilation 76
Proximal convoluted tubule 118
PTSMA See Percutaneous transluminal septal myocardial ablation
patients, uses of 182t
monitoring 136
trials of 179t
artery
systolic pressures 57
wedge pressure 33f
disease 45
embolism 179
function 448
interstitial edema 62
vasodilator challenge 182
Pulmonic stenosis 274
Pulsatile index 458
R
RAAS See Renin-angiotensin-aldosterone system
Ramipril 215
Randomized controlled trial 179
Reactive oxygen species 341
Recent European Society of Cardiology Guidelines 333
Recurrent congestion 125
Red blood cell 336
REDHOT See Rapid Emergency Department Heart Failure Outpatient
Refractory heart failure symptoms 441
Regional wall motion abnormalities 198
Relative dyspnea score 4
REMATCH trial 162
Resolution of giant cell myocarditis under immunosuppression 516f
Reverse transcriptase inhibitors 542
Revolution acute respiratory failure 76f
RHD, prevention of 394
Rheumatoid arthritis See also Polyarteritis nodosum
Riet dierckx 363
S
Sarcoidosis 481
Scar 274
Schistosoma species 507
Senile systemic amyloidosis 480
Serum
amyloid P component scintigraphy 481
neutrophil gelatinase-associated lipocalin levels, management based on 141t
sodium 149
Severe
asymptomatic hypotension 214
cases with cardiogenic shock 502
chronic heart failure 218
systolic dysfunction 400
Short QT syndrome 232
Simpson's rule 55
Singapore heart failure outcomes and phenotypes 374
Single-nucleotide polymorphisms 536
Slow continuous ultrafiltration 167
Smoking cessation 394
SMT, standard medical therapy 264
SNPS See Single-nucleotide polymorphisms
Soap 431
Social welfare contribution 363
Socioeconomic factors 204
Sotalol 28
Stage heart failure 369
Stamatia prapa 365
Standard operational procedures 427
Staphylococcus aureus bacteremia 201
Steady-state free precession 88
Stenotic lesions 274
Stepped pharmacologic therapy 163
Strongyloides stercoralis 507
Suboptimal TTE images 201
Subxiphoid of pericardial effusion 7f
Sudden death in heart failure trial 262
Sulfa-based diuretics 181
Sulfonylureas 343
Sydenham's chorea 390
Sympathico-adrenergic system 315
T
Taenia solium 507
Takayasu arteritis 383
Tandemheart 471
Tandemheart® system and pump 471f
TASH See Transcoronary ablation of septal hypertrophy
Teach-back method concepts 194
TEE, transesophageal echocardiography 457
Telemonitoring 209
Telemonitoring to improve heart failure outcomes 209
Therapy-related factors 204
Thiazide diuretics 119
Thiazolidinediones 343
Thibaud damy 363
Thick ascending limb 118
Thoracis ultrasound 71
Thromboembolic events 242
Ticagrelor 155
Tissue Doppler imaging 56
Tolvaptan 119
Torsemide 119
Toxic conditions with acute myocarditis 507t
Toxoplasma gondii 507
Traditional biomarkers 298
Trajectories of decline 462f
Trandolapril 215
Transcoronary ablation of septal hypertrophy 491
Transient ischemic attack 29
Transition
care nursing roles 422
from intravenous to oral drug regimens 125
to end-of-life care 412
Triamterene 119
Trichinella spiralis 507
Trichinosis 507
Troponin peptide 9
Troubleshooting left ventricular assist device patients 183
Trypanosoma cruzi 507
Tuberculosis prevention 394
U
Universal health literacy principles 194
US carvedilol heart failure program 215
Utility in emergency department 42
V
VAD, ventricular assist device 457
Valsartan heart failure trial 268
in acute heart failure 127
induced
decrease in blood pressure, management of 129
hypotension 129
recommended dose of 128t
Vasopressin
and heart failure 144
antagonists 119
levels of 144
receptor antagonists 120
role of 144
Venoarterial extracorporeal membrane oxygenation 504
Venous access 172
Ventilator associated pneumonia 74
Ventricular
arrhythmias 459
role of 377
enlargement 274
fibrillation 263
rate control 227
systolic function 197
done right 232
types of 236
Ventriculography of
classic apical pattern of takotsubo cardiomyopathy 496f
midventricular variant of takotsubo cardiomyopathy 497f
Veterans health administration 402
Virological analyses of endomyocardial biopsy 512
Vital signs 4
Vitamin K antagonists 240
W
Warfarin
and antiplatelet therapy in chronic heart failure 247
in nonvalvular atrial fibrillation 242
versus aspirin in reduced cardiac ejection fraction 247
Well's criteria 7t
Wet versus dry natriuretic peptide levels 113t
Wolff-Parkinson-White syndrome 226
WPW syndrome See Wolff-Parkinson-White syndrome